抗 CRISPR 蛋白的应用：CRISPR-Cas 技术的天然制动。
Anti-CRISPR protein applications: natural brakes for CRISPR-Cas technologies.
机构信息
Department of Microbiology and Immunology, University of California, San Francisco, CA, USA.
Section of Microbiology, University of Copenhagen, Copenhagen, Denmark.
出版信息
Nat Methods. 2020 May;17(5):471-479. doi: 10.1038/s41592-020-0771-6. Epub 2020 Mar 16.
Abstract
Clustered, regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated (Cas) genes, a diverse family of prokaryotic adaptive immune systems, have emerged as a biotechnological tool and therapeutic. The discovery of protein inhibitors of CRISPR-Cas systems, called anti-CRISPR (Acr) proteins, enables the development of more controllable and precise CRISPR-Cas tools. Here we discuss applications of Acr proteins for post-translational control of CRISPR-Cas systems in prokaryotic and mammalian cells, organisms and ecosystems.
摘要
成簇、规律间隔短回文重复序列 (CRISPR) 和 CRISPR 相关 (Cas) 基因是一类多样化的原核适应性免疫系统，已成为生物技术工具和治疗方法。CRISPR-Cas 系统蛋白抑制剂的发现，即抗 CRISPR（Acr）蛋白，使得更可控和精确的 CRISPR-Cas 工具得以开发。在这里，我们讨论了 Acr 蛋白在原核细胞和哺乳动物细胞、生物和生态系统中转录后调控 CRISPR-Cas 系统的应用。
相似文献
1
Anti-CRISPR protein applications: natural brakes for CRISPR-Cas technologies.抗 CRISPR 蛋白的应用：CRISPR-Cas 技术的天然制动。
Nat Methods. 2020 May;17(5):471-479. doi: 10.1038/s41592-020-0771-6. Epub 2020 Mar 16.
2
The CRISPR-Cas toolbox and gene editing technologies.CRISPR-Cas 工具包和基因编辑技术。
Mol Cell. 2022 Jan 20;82(2):333-347. doi: 10.1016/j.molcel.2021.12.002. Epub 2021 Dec 29.
3
[Research advances on the development and application of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein system].成簇规律间隔短回文重复序列（CRISPR）/CRISPR相关蛋白系统的开发与应用研究进展
Zhonghua Shao Shang Za Zhi. 2021 Jul 20;37(7):681-687. doi: 10.3760/cma.j.cn501120-20200329-00201.
4
Protein Inhibitors of CRISPR-Cas9.CRISPR-Cas9 的蛋白抑制剂。
ACS Chem Biol. 2018 Feb 16;13(2):417-423. doi: 10.1021/acschembio.7b00831. Epub 2018 Jan 17.
5
Recent advances in CRISPR technologies for genome editing.CRISPR 技术在基因组编辑方面的最新进展。
Arch Pharm Res. 2021 Jun;44(6):537-552. doi: 10.1007/s12272-021-01336-4. Epub 2021 Jun 23.
6
Diverse Mechanisms of CRISPR-Cas9 Inhibition by Type II Anti-CRISPR Proteins.多种类型 II 抗 CRISPR 蛋白抑制 CRISPR-Cas9 的机制。
J Mol Biol. 2023 Apr 1;435(7):168041. doi: 10.1016/j.jmb.2023.168041. Epub 2023 Mar 8.
7
Potent Cas9 Inhibition in Bacterial and Human Cells by AcrIIC4 and AcrIIC5 Anti-CRISPR Proteins.AcrIIC4 和 AcrIIC5 抗 CRISPR 蛋白在细菌和人类细胞中对 Cas9 的强效抑制作用。
mBio. 2018 Dec 4;9(6):e02321-18. doi: 10.1128/mBio.02321-18.
8
Current Updates of CRISPR/Cas System and Anti-CRISPR Proteins: Innovative Applications to Improve the Genome Editing Strategies.CRISPR/Cas 系统和抗 CRISPR 蛋白的最新进展：创新应用以改善基因组编辑策略。
Int J Nanomedicine. 2024 Oct 9;19:10185-10212. doi: 10.2147/IJN.S479068. eCollection 2024.
9
CRISPR technologies for bacterial systems: Current achievements and future directions.CRISPR 技术在细菌系统中的应用：当前成就与未来方向。
Biotechnol Adv. 2016 Nov 15;34(7):1180-1209. doi: 10.1016/j.biotechadv.2016.08.002. Epub 2016 Aug 24.
10
Emergent CRISPR-Cas-based technologies for engineering non-model bacteria.基于紧急 CRISPR-Cas 的技术用于工程非模型细菌。
Curr Opin Microbiol. 2023 Oct;75:102353. doi: 10.1016/j.mib.2023.102353. Epub 2023 Jul 4.
引用本文的文献
1
Identification of regulatory sequences in Aca11 and Aca13 for detection of anti-CRISPR and protein-protein interaction.鉴定Aca11和Aca13中的调控序列以检测抗CRISPR和蛋白质-蛋白质相互作用。
Nucleic Acids Res. 2025 Jul 19;53(14). doi: 10.1093/nar/gkaf694.
2
A census of anti-CRISPR proteins reveals AcrIE9 as an inhibitor of K12 Type IE CRISPR-Cas system.一项关于抗CRISPR蛋白的普查显示，AcrIE9是K12 I型E类CRISPR-Cas系统的一种抑制剂。
bioRxiv. 2025 May 10:2025.05.07.652737. doi: 10.1101/2025.05.07.652737.
3
miRNA biomarkers: advancing early detection of acute myocardial infarction.微小RNA生物标志物：推动急性心肌梗死的早期检测
Mikrochim Acta. 2025 Jul 12;192(8):500. doi: 10.1007/s00604-025-07263-1.
4
Harnessing an anti-CRISPR protein for powering CRISPR/Cas9-mediated genome editing in undomesticated Bacillus strains.利用一种抗CRISPR蛋白在未驯化的芽孢杆菌菌株中推动CRISPR/Cas9介导的基因组编辑。
Microb Cell Fact. 2025 Jun 23;24(1):143. doi: 10.1186/s12934-025-02776-z.
5
Synthetic CRISPR Networks Driven by Transcription Factors via Structure-Switching DNA Translators.由转录因子通过结构转换DNA翻译器驱动的合成CRISPR网络。
J Am Chem Soc. 2025 Jun 18;147(24):21184-21193. doi: 10.1021/jacs.5c06913. Epub 2025 Jun 9.
6
Insights from Shigella bacteriophage genomes analysis.志贺氏菌噬菌体基因组分析的见解
Bioinformation. 2024 Dec 31;20(12):2050-2061. doi: 10.6026/9732063002002050. eCollection 2024.
7
Transitioning from wet lab to artificial intelligence: a systematic review of AI predictors in CRISPR.从湿实验室到人工智能的转变：对CRISPR中人工智能预测因子的系统综述
J Transl Med. 2025 Feb 4;23(1):153. doi: 10.1186/s12967-024-06013-w.
8
Isolation and Characterization of Lytic Bacteriophages Capable of Infecting Diverse Multidrug-Resistant Strains of : PaCCP1 and PaCCP2.能够感染多种耐多药菌株的裂解性噬菌体的分离与鉴定：PaCCP1和PaCCP2
Pharmaceuticals (Basel). 2024 Nov 30;17(12):1616. doi: 10.3390/ph17121616.
9
Advances in CRISPR-Cas technology and its applications: revolutionising precision medicine.CRISPR-Cas技术进展及其应用：革新精准医学
Front Genome Ed. 2024 Dec 12;6:1509924. doi: 10.3389/fgeed.2024.1509924. eCollection 2024.
10
Cascade-Cas3 facilitates high-accuracy genome engineering in s using phage-encoded homologous recombination.级联-Cas3利用噬菌体编码的同源重组促进在s中的高精度基因组工程。
Eng Microbiol. 2022 Aug 29;2(4):100046. doi: 10.1016/j.engmic.2022.100046. eCollection 2022 Dec.
本文引用的文献
1
Structures of Neisseria meningitidis Cas9 Complexes in Catalytically Poised and Anti-CRISPR-Inhibited States.脑膜炎奈瑟菌 Cas9 复合物在催化激活和抗 CRISPR 抑制状态下的结构。
Mol Cell. 2019 Dec 19;76(6):938-952.e5. doi: 10.1016/j.molcel.2019.09.025. Epub 2019 Oct 24.
2
Cas9 Allosteric Inhibition by the Anti-CRISPR Protein AcrIIA6.Cas9 别构抑制由抗 CRISPR 蛋白 AcrIIA6 介导
Mol Cell. 2019 Dec 19;76(6):922-937.e7. doi: 10.1016/j.molcel.2019.09.012. Epub 2019 Oct 8.
3
Inhibition of Type III CRISPR-Cas Immunity by an Archaeal Virus-Encoded Anti-CRISPR Protein.古菌病毒编码的抗 CRISPR 蛋白抑制 III 型 CRISPR-Cas 免疫。
Cell. 2019 Oct 3;179(2):448-458.e11. doi: 10.1016/j.cell.2019.09.003. Epub 2019 Sep 26.
4
Anti-CRISPR-Associated Proteins Are Crucial Repressors of Anti-CRISPR Transcription.抗 CRISPR 相关蛋白是抗 CRISPR 转录的关键抑制剂。
Cell. 2019 Sep 5;178(6):1452-1464.e13. doi: 10.1016/j.cell.2019.07.046. Epub 2019 Aug 29.
5
Cell-Type-Specific CRISPR Activation with MicroRNA-Responsive AcrllA4 Switch.具有微小RNA响应性AcrllA4开关的细胞类型特异性CRISPR激活
ACS Synth Biol. 2019 Jul 19;8(7):1575-1582. doi: 10.1021/acssynbio.9b00073. Epub 2019 Jul 9.
6
Inhibition of CRISPR-Cas9 ribonucleoprotein complex assembly by anti-CRISPR AcrIIC2.抗 CRISPR AcrIIC2 抑制 CRISPR-Cas9 核糖核蛋白复合物组装。
Nat Commun. 2019 Jun 26;10(1):2806. doi: 10.1038/s41467-019-10577-3.
7
Use of anti-CRISPR protein AcrIIA4 as a capture ligand for CRISPR/Cas9 detection.利用抗 CRISPR 蛋白 AcrIIA4 作为捕获配体用于 CRISPR/Cas9 检测。
Biosens Bioelectron. 2019 Sep 15;141:111361. doi: 10.1016/j.bios.2019.111361. Epub 2019 May 31.
8
Structural Basis for the Inhibition of CRISPR-Cas12a by Anti-CRISPR Proteins.抗 CRISPR 蛋白抑制 CRISPR-Cas12a 的结构基础。
Cell Host Microbe. 2019 Jun 12;25(6):815-826.e4. doi: 10.1016/j.chom.2019.05.004. Epub 2019 May 30.
9
The next generation of CRISPR-Cas technologies and applications.下一代 CRISPR-Cas 技术与应用
Nat Rev Mol Cell Biol. 2019 Aug;20(8):490-507. doi: 10.1038/s41580-019-0131-5.
10
Production of CRISPR/Cas9-Mediated Self-Cleaving Helper-Dependent Adenoviruses.CRISPR/Cas9介导的自切割辅助依赖型腺病毒的制备
Mol Ther Methods Clin Dev. 2019 Apr 16;13:432-439. doi: 10.1016/j.omtm.2019.04.003. eCollection 2019 Jun 14.
Zotero 插件